Nosopharm

Anti-infective drug discovery targeting the bacterial multidrug resistance to antibiotics

placeNimes, Occitanie, France calendar_todayFounded 2009 groups7 employees language nosopharm.com

Innovation

8 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 206 times.

YearFilings
20122
20131
20141
20152
20163
20173
20183
20191
20201
20212
20242
20251

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital350%
Private equity233%
Bank & private debt117%
Coming soon